Orrstown Financial Services’s GSK GSK Stock Holding History

Orrstown Financial Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-240	Closed	-$12K	–	147
2019 Q3	$12K	Hold	240	–	–	0.02%	179
2019 Q2	$12K	Sell	240 -506	-68%	-$25.4K	0.02%	172
2019 Q1	$39K	Buy	746 +506	+211%	+$25.3K	0.05%	138
2018 Q4	$11K	Buy	+240	New	+$11.8K	0.02%	163
2018 Q2	–	Sell	-208	Closed	-$10K	–	322
2018 Q1	$10K	Sell	208 -32	-13%	-$1.49K	0.01%	226
2017 Q4	$11K	Hold	240	–	–	0.01%	220
2017 Q3	$12K	Buy	240 +40	+20%	+$2.03K	0.01%	221
2017 Q2	$11K	Buy	+200	New	+$10.7K	0.01%	220

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Orrstown Financial Services's GSK Position: Q4 2019 in Review

Orrstown Financial Services sold out of GSK (GSK) in Q4 2019, closing a stake of 240 shares — an estimated $12K sold.

Orrstown Financial Services first reported a position in GSK in Q2 2017 and held it in 8 quarters. The position peaked at $39K in Q1 2019. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Orrstown Financial Services reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Orrstown Financial Services sold 240 GSK shares in Q4 2019, an estimated $12K.
Orrstown Financial Services first reported a position in GSK in Q2 2017 and held it in 8 quarters.
Orrstown Financial Services's GSK position peaked at $39K in Q1 2019.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Orrstown Financial Services's 13F filing for Q4 2019, filed 17 Jan 2020.